Net Cash Provided by (Used in) Operating Activities |
9.04K |
USD |
+22.4% |
Sep 30, 2023 |
Q3 2023 |
Net Cash Provided by (Used in) Financing Activities |
-8.99K |
USD |
+0.76% |
Sep 30, 2023 |
Q3 2023 |
Common Stock, Shares Authorized |
60M |
shares |
0% |
Mar 31, 2024 |
Q1 2024 |
Common Stock, Shares, Issued |
3.29M |
shares |
0% |
Mar 31, 2024 |
Q1 2024 |
Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Mar 31, 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-3.47K |
USD |
+50.5% |
Sep 30, 2023 |
Q3 2023 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
105K |
USD |
+5.47% |
Mar 31, 2024 |
Q1 2024 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
771 |
USD |
+191% |
Sep 30, 2023 |
Q3 2023 |
Deferred Tax Assets, Valuation Allowance |
4.36M |
USD |
+0.01% |
Jun 30, 2023 |
Q2 2023 |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Jun 30, 2023 |
Q2 2023 |
Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
-2.05K |
USD |
+77.6% |
Mar 31, 2024 |
Q1 2024 |
Deferred Income Tax Expense (Benefit) |
0 |
USD |
|
Jun 30, 2023 |
Q2 2023 |
Deferred Tax Assets, Operating Loss Carryforwards |
4.36M |
USD |
+0.01% |
Jun 30, 2023 |
Q2 2023 |
Current Income Tax Expense (Benefit) |
0 |
USD |
|
Jun 30, 2023 |
Q2 2023 |
Additional Paid in Capital |
21.1M |
USD |
0% |
Mar 31, 2024 |
Q1 2024 |
Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
|
Jun 30, 2023 |
Q2 2023 |
Interest Expense |
727 |
USD |
-39.3% |
Dec 31, 2023 |
Q4 2023 |